News

Published on 13 Oct 2024 on Insider Monkey · via Yahoo Finance

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving...


Article preview image

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ranks among the list of stocks with improving technical rating according to Piper Sandler.

The start of October has seen another wild swing for markets. September’s second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut. After an initial muted response from markets predicated on worries that the jumbo 50 basis point rate cut might have been due to economic worries, markets soared. Between the day the rate cut was announced and at the September end, the flagship S&P index and the broader NASDAQ index gained 2.6% and 3.5%, respectively.

NASDAQ.AMPH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to...

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) is set to release its Q3 2024 earnings on Nov 6, 2024...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this pie...

Insider Monkey · via Yahoo Finance 13 Oct 2024

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals...

On June 10, 2024, Floyd Petersen, Director at Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), execut...

GuruFocus.com · via Yahoo Finance 28 May 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphas...

Insider Monkey via Yahoo Finance 9 May 2024

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be...

Amphastar Pharmaceuticals (NASDAQ:AMPH) has had a rough three months with its share price down 19...

Simply Wall St. via Yahoo Finance 3 May 2024

Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares

William Peters, the Chief Financial Officer, Executive Vice President, and Treasurer of Amphastar...

GuruFocus.com via Yahoo Finance 9 Mar 2024

Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), a company specializing in the development, manufactu...

GuruFocus.com via Yahoo Finance 6 Mar 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript February 29, 2024 ...

Insider Monkey via Yahoo Finance 2 Mar 2024

Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance

Net Revenues: $178.1 million for Q4 2023, a 32% increase year-over-year.GAAP Net Income: $36.2 mi...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Institutional investors in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) lost 3.4% last week but...

Key Insights Given the large stake in the stock by institutions, Amphastar Pharmaceuticals' stock...

Simply Wall St. via Yahoo Finance 31 Jan 2024